Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Total Debt (2020)

Historic Total Debt for Maxcyte (MXCT) over the last 1 years, with Q4 2020 value amounting to $4.9 million.

  • Maxcyte's Total Debt changed N/A to $4.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $4.9 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q4 2020, Maxcyte's Total Debt is $4.9 million.
  • In the past 5 years, Maxcyte's Total Debt registered a high of $4.9 million during Q4 2020, and its lowest value of $4.9 million during Q4 2020.